Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis

Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare autoimmune disease characterized by medium and small vessels inflammation. Cardiac vasculitic involvement is one of the most severe manifestations with a significant impact on patients' long-term prognosis: anyway, a specific therap...

Full description

Bibliographic Details
Main Authors: Martina Uzzo, Francesca Regola, Barbara Trezzi, Paola Toniati, Franco Franceschini, Renato Alberto Sinico
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Medicine
Subjects:
Eosinophilic Granulomatosis with Polyangiitis
heart involvement
novel therapies
biologics
rituximab
mepolizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.754434/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.754434/full

Similar Items